13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001325083
Total reported value
$179.3M
$179.3M
38 檔
35.0%
At the close of Q2 2025, Knoll Capital Management, LLC disclosed equity holdings valued at approximately $179.3M, spread across 38 reported holdings.
In Q2 2025, Knoll Capital Management, LLC displayed an active expansion posture, initiating 3 new positions and adding to 3 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALDX | Aldeyra Therapeutics Inc | Stock-Other | 14.91% | +1.36% | — | |
| 2 | BHVN | Biohaven Ltd. | Stock-Other | 8.98% | -10.93% | +7.75% | |
| 3 | ✓ | Entera Bio LTD | Stock-Other | 7.95% | +2.22% | — | |
| 4 | GLD | Spdr Gold Shares | ETF-Commodities | 6.94% | — | — | |
| 5 | MGTX | MeiraGTx Holdings plc | Stock-Other | 5.79% | +3.41% | — | |
| 6 | KGC | Kinross Gold CORP | Stock-Materials | 4.89% | -1.20% | — | |
| 7 | AEM | Agnico Eagle Mines LTD | Stock-Materials | 4.69% | -1.38% | — | |
| 8 | AYS1 | Sandstorm Gold LTD | Stock-Other | 4.68% | — | — | |
| 9 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 3.78% | — | — | |
| 10 | ELTX | Elicio Therapeutics Inc | Stock-Other | 3.46% | -1.10% | — | |
| 11 | SKE | Skeena Resources LTD | Stock-Other | 3.34% | — | -6.34% | |
| 12 | SEA1EUR | Seabridge Gold Inc | Stock-Other | 3.27% | -0.44% | — | |
| 13 | ALT | Altimmune Inc | Stock-Other | 3.09% | — | — | |
| 14 | FNV | Franco-nevada CORP | Stock-Materials | 2.91% | -0.67% | — | |
| 15 | MQ8 | Mag Silver CORP | Stock-Other | 2.55% | — | — | |
| 16 | NUVB | Nuvation Bio Inc | Stock-Other | 2.08% | +1.49% | — | |
| 17 | SLV | Ishares Silver Trust | ETF-Commodities | 1.87% | — | — | |
| 18 | APLT | Applied Therapeutics Inc | Stock-Other | 1.72% | — | — | |
| 19 | OCUL | Ocular Therapeutix Inc | Stock-Other | 1.32% | +3.48% | — | |
| 20 | PM | Philip Morris International | Stock-Consumer Staples | 1.29% | +0.09% | — | |
| 21 | V | Visa Inc-class A Shares | Stock-Financials | 1.22% | — | — | |
| 22 | RGLD | Royal Gold Inc | Stock-Materials | 1.14% | -1.58% | +19.21% | |
| 23 | ITA | Ishares U.s. Aerospace & Def | ETF-Other | 1.03% | +0.10% | — | |
| 24 | BAH | Booz Allen Hamilton Holdings | Stock-Industrials | 0.96% | +2.62% | — | |
| 25 | AGI | Alamos Gold Inc-class A | Stock-Materials | 0.94% | -0.38% | +21.95% | |
| 26 | WPM | Wheaton Precious Metals CORP | Stock-Materials | 0.80% | -0.13% | — | |
| 27 | NOC | Northrop Grumman CORP | Stock-Industrials | 0.77% | -0.20% | — | |
| 28 | CDE | Coeur Mining Inc | Stock-Materials | 0.61% | -0.12% | — | |
| 29 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.50% | — | — | |
| 30 | DEO | Diageo Plc-sponsored Adr | Stock-Consumer Staples | 0.48% | — | — | |
| 31 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 0.47% | — | — | |
| 32 | NEWP | New Pacific Metals CORP | Stock-Other | 0.46% | -0.02% | — | |
| 33 | ✓ | Hookipa Pharma | Stock-Other | 0.44% | — | — | |
| 34 | ABEO | Abeona Therapeutics Inc | Stock-Other | 0.25% | +0.46% | — | |
| 35 | CGAU | Centerra Gold Inc | Stock-Other | 0.12% | -0.36% | — | |
| 36 | OBIO | Orchestra Biomed Holdings In | Stock-Other | 0.12% | — | — | |
| 37 | CRDL | Cardiol Therapeutics Inc-a | Stock-Other | 0.10% | -0.07% | EXIT | |
| 38 | ✓ | Orgenesis, Inc. | Stock-Other | 0.05% | -0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Entera Bio LTD | +1.5% | — | Unchanged |
| 2 | KGC | Kinross Gold CORP | +1.3% | — | Unchanged |
| 3 | SKE | Skeena Resources LTD | +1.3% | -6.34% | Trim |
| 4 | AYS1 | Sandstorm Gold LTD | +1.2% | — | Unchanged |
| 5 | GLD | Spdr Gold Shares | +0.9% | — | Unchanged |
| 6 | ELTX | Elicio Therapeutics Inc | +0.9% | — | Unchanged |
| 7 | NUVB | Nuvation Bio Inc | +0.9% | — | Unchanged |
| 8 | MQ8 | Mag Silver CORP | +0.9% | — | Unchanged |
| 9 | SEA1EUR | Seabridge Gold Inc | +0.9% | — | Unchanged |
| 10 | AEM | Agnico Eagle Mines LTD | +0.8% | — | Unchanged |
| 11 | ✓ | Avadel Pharmaceuticals PLC ADR | +0.7% | — | Unchanged |
| 12 | FNV | Franco-nevada CORP | +0.4% | — | Unchanged |
| 13 | RGLD | Royal Gold Inc | +0.3% | +19.21% | Add |
| 14 | MGTX | MeiraGTx Holdings plc | +0.3% | — | Unchanged |
| 15 | ITA | Ishares U.s. Aerospace & Def | +0.3% | — | Unchanged |
| 16 | PM | Philip Morris International | +0.3% | — | Unchanged |
| 17 | SLV | Ishares Silver Trust | +0.3% | — | Unchanged |
| 18 | ABEO | Abeona Therapeutics Inc | +0.3% | NEW | New buy |
| 19 | CDE | Coeur Mining Inc | +0.2% | — | Unchanged |
| 20 | AGI | Alamos Gold Inc-class A | +0.2% | +21.95% | Add |
| 21 | VRNA | Verona Pharma PLC - Adr | +0.2% | — | Unchanged |
| 22 | WPM | Wheaton Precious Metals CORP | +0.2% | — | Unchanged |
| 23 | CGAU | Centerra Gold Inc | +0.1% | NEW | New buy |
| 24 | OBIO | Orchestra Biomed Holdings In | +0.1% | NEW | New buy |
| 25 | MREO | Mereo Biopharma Group Pl-adr | +0.1% | — | Unchanged |
| 26 | NEWP | New Pacific Metals CORP | +0.1% | — | Unchanged |
| 27 | V | Visa Inc-class A Shares | +0.1% | — | Unchanged |
| 28 | ✓ | Hookipa Pharma | +0.1% | — | Unchanged |
| 29 | BAH | Booz Allen Hamilton Holdings | +0.1% | — | Unchanged |
| 30 | NOC | Northrop Grumman CORP | +0.1% | — | Unchanged |
| 31 | CRDL | Cardiol Therapeutics Inc-a | 0% | — | Unchanged |
| 32 | DEO | Diageo Plc-sponsored Adr | 0% | — | Unchanged |
| 33 | ✓ | Orgenesis, Inc. | 0% | — | Unchanged |
| 34 | ALT | Altimmune Inc | -0.6% | — | Unchanged |
| 35 | APLT | Applied Therapeutics Inc | -0.8% | — | Unchanged |
| 36 | OCUL | Ocular Therapeutix Inc | -1.5% | — | Unchanged |
| 37 | EQX | Equinox Gold CORP | -2.5% | EXIT | Sold out |
| 38 | BHVN | Biohaven Ltd. | -4% | +7.75% | Add |
| 39 | ALDX | Aldeyra Therapeutics Inc | -5.6% | — | Unchanged |
According to official SEC Form 13F filings, Knoll Capital Management, LLC reported a total U.S. public equity portfolio value of $179.3M across 38 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ALDX, BHVN, ENTERA BIO LTD) accounted for 35.0% of total reported equity market value during Q2 2025.
Top New Position Initiated
ABEO
市值: $356.1K
Top Position Liquidated / Trimmed
EQX
前期市值: $3.8M
During Q2 2025, Knoll Capital Management, LLC's top holdings by market value included ALDX (14.9%)、BHVN (9.0%)、ENTERA BIO LTD (8.0%). The largest single position, ALDX, represented 14.9% of total portfolio value.
In Q2 2025, Knoll Capital Management, LLC made 8 total portfolio adjustments, initiating 3 new buys, adding to 3 positions, trimming 1 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.